Revisiting the steatosis‐associated fibrosis estimator score in young Asian subjects with steatotic liver disease and consideration for population variability

Documenti analoghi

• Impact of nomenclature as metabolic associated steatotic liver disease on steatotic liver disease prevalence and screening: a prospective population survey in Asians
  di: Tingfeng Wu, et al.
  Pubblicazione: (2024)
• Incidence of metabolic dysfunction‐associated steatotic liver disease and advanced fibrosis and impact of overweight/obesity in elderly population: a nationwide cohort study
  di: Kunhee Kim, et al.
  Pubblicazione: (2024)
• Prevalence, proportions of elevated liver enzyme levels, and long‐term cardiometabolic mortality of patients with metabolic dysfunction‐associated steatotic liver disease
  di: Yi‐Ting Chen, et al.
  Pubblicazione: (2024)
• Incidence of Osteopenia or Osteoporosis in Asian Patients With Chronic Hepatitis B
  di: Hye Won Lee, et al.
  Pubblicazione: (2025)
• Deciphering metabolic dysfunction‐associated steatotic liver disease: insights from predictive modeling and clustering analysis
  di: Kazuma Mori, et al.
  Pubblicazione: (2024)